Viridian Therapeutics, Inc.
VRDN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $100 | $103 | $156 | $42 |
| Short-Term Investments | $618 | $375 | $269 | $155 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | -$7 | $0 |
| Other Curr. Assets | $21 | $9 | $7 | $3 |
| Total Curr. Assets | $738 | $486 | $425 | $200 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $8 | $1 |
| Total NC Assets | $4 | $4 | $11 | $4 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $742 | $490 | $435 | $204 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $14 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $45 | $23 | $18 | $10 |
| Total Curr. Liab. | $48 | $27 | $33 | $14 |
| LT Debt | $21 | $20 | $5 | $0 |
| Deferred Rev, NC | $0 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $1 | $1 | $1 |
| Total NC Liab. | $23 | $22 | $7 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $71 | $48 | $40 | $16 |
| Equity | – | – | – | – |
| Pref Stock | $189 | $207 | $142 | $134 |
| Common Stock | $1 | $1 | $0 | $0 |
| Retained Earnings | -$996 | -$726 | -$488 | -$358 |
| AOCI | -$0 | $0 | -$0 | -$0 |
| Other Equity | $1,478 | $961 | $741 | $412 |
| Total Equity | $672 | $442 | $395 | $188 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $742 | $490 | $435 | $204 |
| Net Debt | -$78 | -$82 | -$150 | -$42 |